【获纳入恒生综指 礼邦医药-B(09637.HK)有望跻身港股通】智通财经APP获悉，8月21日，恒生指数公司公布截至2026年6月30日的恒生指数系列季度检讨结果，其中礼邦医药-B(09637.HK)获纳入恒生综合指数。指数变动将于9月4日(星期五)收市后实施，并于9月7日(星期一)起生效，届时沪深交易所将相应调整港股通可投资标的范围。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.